Skip to main navigation Skip to search Skip to main content

Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005-2016: a national database linkage study

  • Scott A. McDonald (Lead / Corresponding author)
  • , Stephen T. Barclay
  • , Sharon J. Hutchinson
  • , Adrian J. Stanley
  • , Andrew Fraser
  • , John F. Dillon
  • , Hamish A. Innes
  • , Erica Peters
  • , Nicholas Kennedy
  • , Andrew Bathgate
  • , Peter Bramley
  • , Judith Morris
  • , David J. Goldberg
  • , Peter C. Hayes

    Research output: Contribution to journal › Article › peer-review

    298 Downloads (Pure)

    Abstract

    Background: Primary measures for preventing morbidity and mortality associated with bleeding gastroesophageal varices in cirrhotic patients include endoscopic screening.

    Aim: To identify factors associated with (a) screening and (b) first hospital admission for variceal bleeding among cirrhotic hepatitis C virus (HCV) patients attending specialist care in Scotland.

    Methods: The Scottish Hepatitis C Clinical Database was linked to national hospitalisation and deaths records to identify all chronic HCV patients diagnosed with compensated cirrhosis in 2005-2016 (n = 2741). The adjusted odds of being screened by calendar year period were estimated using logistic regression, and the adjusted hazard ratio (HR) of a first variceal bleed using Cox regression.

    Results: About 34% were screened within the period starting 12 months before and ending 12 months after cirrhosis diagnosis. The proportion screened was stable in 2005-2010 at 42%, declining to 37% in 2011-2013 and 26% in 2014-2016. Odds of screening were decreased for age-groups <40 (OR = 0.61, 95% CI: 0.48-0.77) and 60+ years (OR = 0.67, 95% CI: 0.48-0.94), history of antiviral therapy (OR = 0.70, 95% CI: 0.55-0.89), and cirrhosis diagnosis in 2014-2015, compared with 2008-2010 (OR = 0.67, 95% CI: 0.52-0.86). Compared with 2008-2010, there was no evidence for an increased/decreased relative risk of a first variceal bleed in any other period, but viral clearance was associated with a lower risk (HR = 0.56, 95% CI: 0.32-0.97).

    Conclusions: Overall screening uptake following cirrhosis diagnosis was low, and the decline into the IFN-free therapy era is of concern. The stable bleeding risk over time may be attributable both to ongoing prevention initiatives and to changing diagnostic procedures creating a patient pool with milder disease in more recent years.

    Original languageEnglish
    Pages (from-to)425-434
    Number of pages10
    JournalAlimentary Pharmacology & Therapeutics
    Volume50
    Issue number4
    Early online date3 Jun 2019
    DOIs
    Publication statusPublished - Aug 2019

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Oesophageal and gastric varices
    • endoscopy
    • screening
    • hepatitis C virus
    • gastrointestinal haemorrhage

    ASJC Scopus subject areas

    • Gastroenterology
    • Pharmacology (medical)
    • Hepatology

    Fingerprint

    Dive into the research topics of 'Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005-2016: a national database linkage study'. Together they form a unique fingerprint.

    Cite this